Global Genome Editing Market - Growth, Trends and Forecasts (2017 - 2022)

  • ID: 4402775
  • Report
  • Region: Global
  • 119 pages
  • Mordor Intelligence
1 of 5


  • Genscript Usa Inc.
  • Merck & Co.
  • Origene Technologies Inc.
  • Sangamo Biosciences Inc.
  • MORE
The global genome editing market is estimated to be USD XX billion in 2017 and is expected to reach USD XX billion by 2022, registering a CAGR of XX%, during 2017-2022 (forecast period).

Genome editing is a modern procedure, which is used to modify DNA within a cell, accurately and efficiently. In this form of genetic engineering, a DNA is inserted, replaced or deleted in the genome of a living organism, using genetically engineered nucleases. Genetic engineering is a vital, emerging field in biology.

The genome editing market is driven by the increase in genetically modified crops production, as well as technological advancements & government funding of genomics. Although, the market is poised to grow in the future, certain factors such as high cost of genomic equipment and ethical concerns related to genetic research can hinder the market growth.

The global genome editing market has been segmented based on technology, application, end-user and geography. Based on technology, the market is segmented into CRISPR, TALEN, ZFN, Antisense and others. Based on the application type, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering and others. Further, by end-users, the market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes and contract research organizations. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa and South America. These regions are further segmented into countries in their respective regions.

Some of the major players in the market are:

Thermo Fisher Scientific, Inc
Sangamo Biosciences, Inc
Genscript USA Inc
Horizon Discovery Group PLC
Merck & Co.

OriGene Technologies, Inc
Transposagen Biopharmaceuticals, Inc

Key Deliverables

Market analysis, with region-specific assessments and competition analysis on a global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, growing prospective opportunities, and identification of key companies that can influence the market.

Extensively researched competitive landscape section with profiles of major companies, along with their market share.

Identification and analysis of the macro and micro factors that affect the market on both, global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-range of knowledge and insights about the major players in the industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions where the industry is growing and identify the regions that are still untapped.
Note: Product cover images may vary from those shown
2 of 5


  • Genscript Usa Inc.
  • Merck & Co.
  • Origene Technologies Inc.
  • Sangamo Biosciences Inc.
  • MORE
1. Introduction
1.1 Market Definition
1.2 Research Methodology

2. Executive Summary

3. Key Inferences

4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products and Services
4.2.5 Competitive Rivalry within the Industry

5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Rise in Production of Genetically Modified Crops
5.1.2 Technological Advancements & Rising Government Funding and Growth in the Number of Genomics Projects
5.1.3 Increase in Demand for Synthetic Genes
5.2 Market Restraints
5.2.1 High Cost of Genomic Equipment
5.2.2 Ethical Concerns Related to Genetic Research
5.3 Market Opportunities
5.4 Market Challenges

6. Market Segmentation
6.1 By Technology
6.1.1 CRISPR
6.1.2 TALEN
6.1.3 ZFN
6.1.4 Antisense
6.1.5 Other Technologies
6.2 By Application
6.2.1 Cell Line Engineering
6.2.2 Animal Genetic Engineering
6.2.3 Plant Genetic Engineering
6.2.4 Other Applications
6.3 By End User
6.3.1 Biotechnology & Pharmaceutical Companies
6.3.2 Academic & Government Research Institutes
6.3.3 Contract Research Organizations
6.4 By Geography
6.4.1 North America United States Canada Mexico
6.4.2 Europe United Kigdom Spain Italy France Germany Rest of Europe
6.4.3 Asia Pacific India China Japan Australia South Korea Rest of APAC
6.4.4 South America Brazil Argentina Rest of South America
6.4.5 Middle East and Africa GCC Countries South Africa Rest of MEA

7. Competitive Landscape
7.1 Mergers and Acquisitions
7.2 Partnerships, Collaborations and Agreements
7.3 New Product Launches

8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.2 Sangamo Biosciences, Inc.
8.3 GenScript USA, Inc.
8.4 Horizon Discovery Group plc
8.5 Merck & Co.
8.6 Origene Technologies, Inc.
8.7 Transposagen Biopharmaceuticals, Inc.
8.8 New England Biolabs, Inc.
8.9 Lonza Group Ltd.
8.10 Integrated DNA Technologies, Inc.
8.11 Others

9. Future Market Scenario
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Thermo Fisher Scientific Inc.
  • Sangamo Biosciences Inc.
  • Genscript Usa Inc.
  • Horizon Discovery Group Plc
  • Merck & Co.
  • Origene Technologies Inc.
  • Transposagen Biopharmaceuticals Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown